Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Studsvik’s Interim Report for the Fourth Quarter 2020

· Sales in the fourth quarter increased by 8 per cent in local currency and amounted to SEK 213.5 (202.6) million. · Operating profit was SEK 9.8 (20.4) million. · The free cash flow improved to SEK 39.7 (7.2) million. · The Board of Directors proposes a dividend of SEK 1 per share. · The Annual General Meeting is postponed to June 23, 2021, to increase the chances of physical attendance.  Oct-Dec Oct-Dec Full year Full year 2019 2020 2019 2020Sales, SEK million 213.5 202.

Invitation to webcast for the presentation of Formpipe’s fourth quarter and full year 2020 results

Formpipe’s fourth quarter and full year 2020 results will be published on Tuesday, February 16, 2021, at 08:45 CET. The same day at 01.00-02.00 PM CET; analysts, investors, media and other interested parties are invited to attend a webcast where Formpipe’s CEO, Christian Sundin, will comment on the published report and answer questions. The presentation and question & answers will be given in English. How to participate in the webcast Link to register for the event: https://www.lyyti.in/LIVE_Q_Formpipe_Software__Feb_16th_0854 Live broadcast of the event will be available

SimCorp A/S – Announcement of Managers’ Transactions

Announcement and public disclosure of transactions in SimCorp A/S shares by persons discharging managerial responsibilities and persons closely associated with them 1. Details of the person with managerial responsibilities/person closely associateda) Name Klaus Holse2. Reason for the notificationa) Position/status Chief Executive Officerb) Initial Initial notification notification/Amendment3. Details of the issuer, emission allowance market participant, auction platform,

DDM provides business update with record collections and cash EBITDA

DDM Holding AG (First North Growth Market: DDM) is publishing the following business update for the full year 2020. Record net collections of above EUR 110 million and cash EBITDA of about EUR 100 million. Strong capital position with an equity ratio in the DDM Debt Group of about 30%. Estimated Remaining Collections (120 months) at 31 December 2020 of over EUR 250 million. The majority of the ERC is secured and is expected to be received in the next three years. Cash of EUR 31 million and net debt has decreased by 34% compared to end of 2019 standing at EUR 90 million in the

DDM Debt provides business update with record collections and cash EBITDA

DDM Debt AB (publ) (Nasdaq Stockholm: DDM2) ("DDM Debt") is publishing the following business update for the full year 2020. Record net collections of above EUR 110 million and cash EBITDA of about EUR 100 million. Strong capital position with an equity ratio in the DDM Debt Group of about 30%. Estimated Remaining Collections (120 months) at 31 December 2020 of over EUR 250 million. The majority of the ERC is secured and is expected to be received in the next three years. Cash of EUR 31 million and net debt has decreased by 34% compared to end of 2019 standing at EUR 90 million

Invitation to Q4 2020 webcast

Zalaris ASA will release its fourth quarter 2020 results on Friday 19 February 2021.Zalaris will host a webcast for all shareholders and interested parties on 19 February at 08:30 CET. There will be a Q&A session following the management presentation. Link to webcast will be available on ir.zalaris.com. Contact: Gunnar Manum, CFOMobil: +47 95 17 91 90 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

AcouSort secures technology rights from DTU

AcouSort AB (“AcouSort”) has signed an agreement obtaining the rights to acquire an invention from the Technical University of Denmark (“DTU”). The invention relates to technology developed by Professor Henrik Bruus at DTU in collaboration with AcouSort and concerns a new and more efficient way of manufacturing AcouSort's acoustic chip.”With this new technology, the future AcouSort separation chips will be easier to manufacture at high volumes in a more cost-effective way. By signing this agreement, we ensure that AcouSort stays in the absolute front line of developing acoustofluidics for

BioStock Studio: Rhovac’s CEO comments on the year-end report

This morning Lund-based drug developer Rhovac released its year-end report. CEO Anders Månsson visited BioStock’s studio to tell us more about the company’s challenges and achievements during 2020 as well as the company’s development plan going forward. Månsson points out that the company has entered 2021 on solid ground and with strong finances, and is now continuing development and recruitment for the ongoing phase IIb study.Watch the full interview at biostock.se: https://www.biostock.se/en/biostock-studio-rhovacs-ceo-comments-on-the-year-end-report/This is a press release from

poLight ASA: Invitation to presentation of Q4 2020 results

poLight ASA will release its fourth quarter 2020 results on Friday 19 February 2021 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 08:30 am CEST through live webcast.Please join the Q4 2020 results webcast by clicking here: https://channel.royalcast.com/landingpage/hegnarmedia/20210219_2/ 

PROVENTUS CAPITAL PARTNERS IV ISSUES NEW DEBENTURES

PRESS RELEASE Proventus Capital Partners IV AB (publ) today announces that on 12 February 2021, the company will increase its contributed capital by EUR 15.5 million through the issuance of 154,240 series A1 participation loan debentures at a price of EUR 100 each and by an equity contribution of EUR 0.06 million. The new debentures will be eligible for coupon payments from the second quarter 2021. Including the newly issued debentures, Proventus Capital Partners IV’s funding amounts to EUR 127.7 million comprised of series A1 participation loan debentures of EUR 127.2 million and

PROVENTUS CAPITAL PARTNERS IV B ISSUES NEW DEBENTURES

PRESS RELEASE Proventus Capital Partners IV B AB (publ) today announces that on 12 February 2021, the company will increase its contributed capital by EUR 49.3 million through the issuance of 216,400 series A1 and 20,000 series A2 participation loan debentures at a price of EUR 100 each and 25,500 series B participation loan debentures at a price of EUR 1,000 each and by an equity contribution of EUR 0.18 million. The new debentures will be eligible for coupon payments from the second quarter 2021. Including the newly issued debentures, Proventus Capital Partners IV B’s funding

Kemira signs a new wind power deal to further reduce GHG emissions

Kemira Oyj, Press Release, February 12, 2021 at 12.00 pm (EET)Kemira signs a new wind power deal to further reduce GHG emissions Kemira and Statkraft have signed a new 10 year power purchase agreement to deliver 43.8 GWh renewable wind energy per year to Kemira’s Finnish sites. The wind power is sourced from the Statkraft’s Harbaksfjellet wind farm in Norway. It is part of Europe’s largest onshore wind project, the Fosen Wind. The first renewable energy purchase agreement between Kemira and Statkraft was signed in 2020. Kemira has set an ambitious climate target of 30% reduction in

First patient treated in TIKOMED’s Phase II study of clinical islet transplantation in patients with brittle diabetes

Viken – 12th February 2021 – TIKOMED, a specialty pharmaceutical company developing an infusion product for improving the outcome in cell therapies, today announced that the first patient has been treated in TIKOMED’s ongoing Phase II international, multicenter study – NNCIT-02.   In the NNCIT-02 study, brittle diabetes patients being transplanted with islets of Langerhans are treated with IBSOLVMIR® which has shown to be able to address the instant blood-mediated inflammatory reaction (IBMIR) occurring as an innate immune reaction to the infusion of transplanted cells. Previously, in

Flowscape wins new contract in USA

A large global consulting company expands its Flowscape installation to a new office in the United States. The customer now use the solution at 21 of their North American offices. The total value of this order is 265,000 SEK the first year and thereafter 70,000 SEK annually.“We have the pleasure of expanding with one of our major customers in North America. The customer sees great value with Flowcape's comprehensive solution and that we fulfill the high demands on functionality, safety and flexibility for their employees. We have continuously adapted our solution to the market's local

EPTI broadens the circle of owners and increases Net Asset Value to over SEK 370M

Stockholm February 12, 2021Despite the current global situation, 2020 was summed up as the best year in the company's history. EPTI has gone from 50 to 100 employees, established itself in two new countries and seen the company's Net Asset Value increase by over 70%.During the winter, the startup factory EPTI brought in new shareholders and partners as part of the strategy to increase exposure to various industries through investors with industry expertise.Among the existing and new shareholders who bought shares are Sebastian Nyaiesh via his family office AllaNova (lawyer, angel

Proposal for election of board members in Nexam Chemcial Holding AB

The Nomination Committee proposes re-election of the Board members Mats Persson, Cecilia Jinert Johansson and Jonna Opitz as regular Board members and election of Martin Roos and Oskar Tuwesson as new regular Board members. Ronnie Törnqvist has declined re-election. Mats Persson is proposed for re-election as Chairman of the Board.Note: This news has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For more information, please contact: Mats Persson, Chairman of the Board, +46-706 32 29 23,

DecideAct implements blockchain technology

As an added security for the validity and governance of strategic data on DecideAct’s Strategy Execution Management platform, the software company is now adopting blockchain technology. This makes DecideActs strategic governance and data integrity a leader in the category.The governance blockchain solution for strategy means that DecideAct can guarantee customers full documentation for all data contained in the system. The database provides a transparent, immutable and cryptographically verifiable transaction log owned by a central trusted third party authority. This not only ensures data

Resolutions from Bambuser's extra general meeting on 12 February 2021

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURESThe extra general meeting of Bambuser AB ("Bambuser" or the "Company") was held today on 12 February 2021 in Stockholm and the following resolutions were passed by the meeting. Approval of the boards' resolution to

Update of the financial calendar

Brighter has changed the date of publication of the year-end report (Q4) 2020 to 26 February 2021. For further information, please contact: Investor RelationsIR@brighter.se Ann Zetterberg, CFO+46 708 37 21 23ann.zetterberg@brighter.se Certified AdviserBrighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se. About Brighter AB (publ)Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to

Q-Free: Mandatory notification of trade by primary insider

(Oslo, 12 February 2021) Geir Bjørlo, member of the Board of directors of Q-Free ASA, has today acquired 47,146 shares in Q-Free ASA at an average price of NOK 5.45 per share. The shares were acquired through Illuminator AS, a company controlled by Bjørlo. Following the transaction, Bjørlo controls 117,146 shares in Q-Free ASA. This information is subject to disclosure requirements pursuant to §4-2 of the Norwegian Securities Trading Act.

Lindesberg Hälsocenter maximize natural light with an indoor park framed with glass facades and glass roof

The architecture of well-being is not something new. Some would say it already started in the beginning of early 20th century as a part of the modern movement. Healthy housing was a core concept already then, and a lot of buildings were built in the endeavor to improve well-being through design. The common thread of this type of architecture is copious amounts of natural light, views of the outside and the use of top modern technology. Lindesberg hälsocenter is no exception, the building was designed with modern technology tools such as daylight simulation, energy calculations and analyses of

Invitation to presentation of SBB’s year-end report 2020

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) will publish its year-end report for 2020 on 23 February 2021 at 08:00 CET. SBB’s CEO Ilija Batljan will present the results on the same day at 10:00 CET via conference call and webcast. The presentation will be held in English and will be concluded with a Q&A session. Questions can be asked on the conference call or in written form through the webcast. No pre-registration is needed. The report will be available at: https://corporate.sbbnorden.se/en/reports-and-presentations/ Webcast link: https://tv.streamfabriken.com/

Invitation to presentation of Nanoform’s year-end report for 2020 on February 26, 2021

Press release Nanoform Finland Plc February 12, 2021 11:00 a.m. Finnish time / 10:00 a.m. Swedish time   Invitation to presentation of Nanoform’s year-end report for 2020 on February 26, 2021 Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, will publish its year-end report for 2020 on February 26, 2021, at 8.10 a.m. Finnish time / 7.10 a.m. Swedish time. The company will hold a conference call and an online presentation on the same day at 3.00 p.m. Finnish time / 2.00 p.m. Swedish time. Nanoform will be

Publishing of Apetit Plc’s Financial Statements Release 2020 on 19 February 2021

Apetit Plc, Press release 12 February 2021 at 11:00 a.m.Apetit Plc will publish its Financial Statements Release for 2020 on Friday, 19 February 2021 at 8:30 a.m. The release can be found on the company’s website at apetit.fi after its publishing. A news conference (in Finnish) will be held as a live webcast on 19 February 2021 at 10:00. The news conference can be followed at apetit.fi/for-investors. The presentation material and a recording of the webcast will be available on the company’s website after the news conference. Apetit Plc For more information, please contact: Sanna

There are no items matching the current filter
There are no more items matching the current filter
Back to top